Clinical Trials Logo

Smoking Cessation clinical trials

View clinical trials related to Smoking Cessation.

Filter by:

NCT ID: NCT03717662 Recruiting - Smoking Cessation Clinical Trials

Promoting Women's Health: A Gender Specific Smoking Cessation Program for Female Smokers in Hong Kong

Start date: April 1, 2006
Phase: N/A
Study type: Interventional

This project aims to publicize quitting among female smokers, and encourage and support those who want to quit by providing face-to-face and/or telephone counseling. The objectives are to: 1. Build up a Women Against Tobacco Taskforce (WATT) with woman volunteers from various organizations to promote quitting in female smokers, and to arouse public awareness of the effects of smoking on sexual, reproductive and child health, and other diseases among women. 2. Conduct a survey among the women volunteers and staff of the women's organization to ascertain their learning needs, knowledge, attitudes, and practice of tobacco control and smoking cessation, and to identify interested participants to join the smoking cessation training program. 3. Design and deliver a smoking cessation counseling training program (based on the learning needs identified), to equip women volunteers with the knowledge and skills in smoking cessation. 4. Develop and evaluate a gender-specific smoking cessation program to help female smokers to reduce and quit smoking. 5. Promote women's health and quality of life, and reduce the life-long morbidity and mortality of female smokers in the long term. 6. Examine the long term (3-year) impact of a gender-specific smoking cessation program on the smoking behaviors of female smokers. 7. Examine another long-term (6-year) impact of a gender-specific smoking cessation program on the smoking behaviors of female smokers. 8. Ascertain the contributing factors in the rate of quitting, retention and relapse. 9. Investigate Hong Kong women smokers awareness and attitude to women quitline.

NCT ID: NCT03670316 Recruiting - HIV Clinical Trials

Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care

Start date: August 17, 2020
Phase: Phase 4
Study type: Interventional

To determine the efficacy of an algorithm designed to recommend smoking cessation-related pharmacotherapy options to the primary care providers of smokers living with HIV/AIDS.

NCT ID: NCT03631212 Recruiting - Smoking Cessation Clinical Trials

Avatar-led Acceptance and Commitment Therapy Smoking Cessation

Flexiquit
Start date: September 15, 2017
Phase: N/A
Study type: Interventional

Smoking remains a global concern, especially for youth where developmentally-suited smoking cessation programs are lacking and especially among those not presenting for treatment on their own. We aimed to assess the effectiveness of an avatar-led digitalized smoking cessation intervention (Flexiquit) based on Acceptance and Commitment Therapy (ACT) for young adult smokers at all levels of motivation to quit.

NCT ID: NCT03630614 Recruiting - Smoking Cessation Clinical Trials

Randomized Trial of Electronic Cigarettes With or Without Nicotine in Smoking Cessation.

ECSMOKE
Start date: October 17, 2018
Phase: Phase 3
Study type: Interventional

Background: Electronic cigarettes (EC) mainly containing nicotine (88-95 % of users) are widely and growingly used worldwide. It is estimated that there were 1.7 million daily users in France in 2016. Although the number of publications about its use is increasing exponentially, there are no evidence based, unbiased, head-to-head comparison data about its efficacy as an aid to smoking cessation. As of today, only two head-to-head randomized studies have been published, both reported negative results at the main endpoint but they used first and second generation EC delivering nicotine with low or unknown bioavailability. Recent EC deliver nicotine with largely improved bioavailability. One of the randomized studies compared EC with and without nicotine to nicotine patch and reported similar smoking cessation rate at main outcome. However, there is no published, double blind study comparing EC use with a well-studied, licensed smoking cessation medication. Superiority of EC with nicotine compared to EC without nicotine and to a reference smoking cessation medication while collecting also straightforward information about safety, would allow proposing EC with nicotine to the large population of smokers who intend to quit and situate it among the approved smoking cessation treatments. The clinical study's hypothesis: EC containing nicotine can be considered as a nicotine replacement therapy having, probably, a better bioavailability of nicotine than the marketed pharmaceutical NRTs, first line medications of smoking cessation. It is therefore of interest to compare EC containing nicotine to EC without nicotine but also to a reference medication with demonstrated efficacy in smoking cessation. We hypothesize that EC with nicotine provides a higher smoking abstinence rate than EC without nicotine and may be as good as varenicline, our reference medication.

NCT ID: NCT03553979 Recruiting - Stress Clinical Trials

Grip&Health: Behavioural Intervention to Reduce Smoking, Stress and Improve Financial Health in Low-SES in Rotterdam

Grip&Health
Start date: January 9, 2018
Phase: N/A
Study type: Interventional

Grip&Health: randomised trial which will examine the effect of theory-based multicomponent behavioural intervention for reducing stress, smoking and improving financial health and perceived health of low-SES residents in Rotterdam. Between January 2018 and July 2018, a total of 300 participants will be recruited and randomised either to a stress management program (SM), stress management with a buddy program (SM-B) or a control condition. The investigators hypothesise that compared to participants in the control condition, participants in the intervention arms will demonstrate reduced stress, reduced smoking and improved financial health and perceived health.

NCT ID: NCT03480113 Recruiting - Smoking Cessation Clinical Trials

The Effectiveness of Mindfulness-based Intervention on Smoking Cessation

Start date: March 16, 2018
Phase: N/A
Study type: Interventional

The present study will carry out a workplace health promotion via MBI to help smoking workers to quit smoking.

NCT ID: NCT03452124 Recruiting - Smoking Cessation Clinical Trials

The Effects of I Quit Ordinary Smoking on the Arterial Wall and Endothelial Glycocalyx Properties of Smokers

Start date: March 30, 2018
Phase: N/A
Study type: Interventional

I quit ordinary smoking (IQOS) is proposed as a bridge to smoking cessation. In this study the investigators will examine its effects on aortic elasticity, glycocalyx integrity, and exhaled carbon monoxide (CO) concentration, both acutely and after 1 month of use.

NCT ID: NCT03264313 Recruiting - Smoking Cessation Clinical Trials

Deep Transcranial Magnetic Stimulation (dTMS) to Induce Smoking Cessation

SmokCessdTMS
Start date: January 16, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of dTMS used as a tool for the smoking cessation; therefore, the subjects will be randomized to be treated on the active group or to receive placebo stimulation.

NCT ID: NCT03253445 Recruiting - Smoking Cessation Clinical Trials

Individual Acceptance and Commitment Therapy (ACT) for Smoking Cessation for Schizophrenic Patients

Start date: July 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy of using Acceptance and commitment therapy for smoking cessation for schizophrenic patients.

NCT ID: NCT03251053 Recruiting - Smoking Cessation Clinical Trials

Adverse Airway Effects From Tobacco and E-Cigarettes

Start date: March 28, 2016
Phase: N/A
Study type: Interventional

The purpose of the study conducted at VA Medical Center in Miami is to determine if smoking electronic cigarettes (known as e-cigarettes) that contain nicotine have less negative effects than regular cigarettes on the person's respiratory health. We will assess this by measuring pulmonary function tests, several body molecules and functionality of the airway cells. We will also evaluate how smokers can maintain exclusive electronic cigarettes use. In this study, some people will continue to smoke regular tobacco cigarettes while others will switch to a nicotine-containing electronic cigarette.